Which has better valuation and earnings, MCK or DXCM?

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $38.47 22.29 DexCom $4.66B 6.75 $836.30M $2.53 32.98

Is MCK or DXCM more profitable?

DexCom has a net margin of 20.12% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 35.94% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% DexCom 20.12% 35.94% 14.75%

Does the media prefer MCK or DXCM?

In the previous week, DexCom had 11 more articles in the media than McKesson. MarketBeat recorded 53 mentions for DexCom and 42 mentions for McKesson. McKesson's average media sentiment score of 1.18 beat DexCom's score of 0.92 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 29 Very Positive mention(s) 9 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 22 Very Positive mention(s) 4 Positive mention(s) 18 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $38.47 22.29 HealthEquity $1.34B 6.29 $215.20M $2.67 37.68

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% HealthEquity 17.25% 14.75% 9.22%

Does the media prefer MCK or HQY?

In the previous week, McKesson had 34 more articles in the media than HealthEquity. MarketBeat recorded 42 mentions for McKesson and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.74 beat McKesson's score of 1.18 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 29 Very Positive mention(s) 9 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better earnings & valuation, HSIC or MCK?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.74 $398M $3.31 25.91 McKesson $403.43B 0.25 $4.76B $38.47 22.29

Is HSIC or MCK more profitable?

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Henry Schein 2.95% 15.44% 5.53% McKesson 1.18% -345.35% 5.85%

Does the media prefer HSIC or MCK?

In the previous week, McKesson had 26 more articles in the media than Henry Schein. MarketBeat recorded 42 mentions for McKesson and 16 mentions for Henry Schein. McKesson's average media sentiment score of 1.18 beat Henry Schein's score of 0.48 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 3 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral McKesson 29 Very Positive mention(s) 9 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MCK or MMSI?

In the previous week, McKesson had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 42 mentions for McKesson and 35 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.22 beat McKesson's score of 1.18 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 29 Very Positive mention(s) 9 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 20 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or MCK?

In the previous week, McKesson had 33 more articles in the media than AMN Healthcare Services. MarketBeat recorded 42 mentions for McKesson and 9 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.18 beat AMN Healthcare Services' score of 0.83 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 29 Very Positive mention(s) 9 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

McKesson (MCK) Competitors

$857.61 +1.42 (+0.17%)

Closing price 07/31/2026 03:59 PM Eastern

Extended Trading

$857.36 -0.25 (-0.03%)

As of 07/31/2026 07:57 PM Eastern

Compare

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

Should you buy McKesson stock or one of its competitors? MarketBeat compares McKesson with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with McKesson include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN).

How does McKesson compare to DexCom?

McKesson (NYSE:MCK) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

McKesson presently has a consensus target price of $962.67, suggesting a potential upside of 12.25%. DexCom has a consensus target price of $88.13, suggesting a potential upside of 5.60%. Given McKesson's higher possible upside, equities analysts plainly believe McKesson is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$38.47	22.29
DexCom	$4.66B	6.75	$836.30M	$2.53	32.98

McKesson has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, DexCom has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market.

DexCom has a net margin of 20.12% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 35.94% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
DexCom	20.12%	35.94%	14.75%

In the previous week, DexCom had 11 more articles in the media than McKesson. MarketBeat recorded 53 mentions for DexCom and 42 mentions for McKesson. McKesson's average media sentiment score of 1.18 beat DexCom's score of 0.92 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	29 Very Positive mention(s)	9 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	22 Very Positive mention(s)	4 Positive mention(s)	18 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

85.1% of McKesson shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

DexCom beats McKesson on 12 of the 17 factors compared between the two stocks.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$38.47	22.29
HealthEquity	$1.34B	6.29	$215.20M	$2.67	37.68

McKesson currently has a consensus target price of $962.67, suggesting a potential upside of 12.25%. HealthEquity has a consensus target price of $110.93, suggesting a potential upside of 10.26%. Given McKesson's stronger consensus rating and higher possible upside, equities research analysts plainly believe McKesson is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77

In the previous week, McKesson had 34 more articles in the media than HealthEquity. MarketBeat recorded 42 mentions for McKesson and 8 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.74 beat McKesson's score of 1.18 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	29 Very Positive mention(s)	9 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

McKesson has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
HealthEquity	17.25%	14.75%	9.22%

Summary

McKesson and HealthEquity tied by winning 8 of the 16 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

In the previous week, McKesson had 26 more articles in the media than Henry Schein. MarketBeat recorded 42 mentions for McKesson and 16 mentions for Henry Schein. McKesson's average media sentiment score of 1.18 beat Henry Schein's score of 0.48 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	3 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
McKesson	29 Very Positive mention(s)	9 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Henry Schein has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.74	$398M	$3.31	25.91
McKesson	$403.43B	0.25	$4.76B	$38.47	22.29

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.95%	15.44%	5.53%
McKesson	1.18%	-345.35%	5.85%

Henry Schein currently has a consensus target price of $89.36, indicating a potential upside of 4.21%. McKesson has a consensus target price of $962.67, indicating a potential upside of 12.25%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

McKesson (NYSE:MCK) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

McKesson presently has a consensus target price of $962.67, suggesting a potential upside of 12.25%. Merit Medical Systems has a consensus target price of $100.30, suggesting a potential upside of 17.99%. Given Merit Medical Systems' higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Merit Medical Systems has a net margin of 9.22% compared to McKesson's net margin of 1.18%. Merit Medical Systems' return on equity of 13.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Merit Medical Systems	9.22%	13.75%	8.10%

McKesson has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.48, suggesting that its share price is 52% less volatile than the broader market.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$38.47	22.29
Merit Medical Systems	$1.52B	3.35	$128.49M	$2.42	35.13

In the previous week, McKesson had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 42 mentions for McKesson and 35 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.22 beat McKesson's score of 1.18 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	29 Very Positive mention(s)	9 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	20 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats McKesson on 10 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market.

McKesson has a net margin of 1.18% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
McKesson	1.18%	-345.35%	5.85%

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

AMN Healthcare Services presently has a consensus target price of $29.00, indicating a potential downside of 14.05%. McKesson has a consensus target price of $962.67, indicating a potential upside of 12.25%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.48	-$95.70M	-$0.87	N/A
McKesson	$403.43B	0.25	$4.76B	$38.47	22.29

In the previous week, McKesson had 33 more articles in the media than AMN Healthcare Services. MarketBeat recorded 42 mentions for McKesson and 9 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.18 beat AMN Healthcare Services' score of 0.83 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	29 Very Positive mention(s)	9 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$100.41B	$9.89B	$6.86B	$23.67B
Dividend Yield	0.38%	2.53%	2.59%	4.22%
P/E Ratio	22.29	25.44	282.27	31.00
Price / Sales	0.25	4.73	581.52	19.22
Price / Cash	18.79	26.24	28.60	18.73
Price / Book	-59.10	5.14	10.93	4.76
Net Income	$4.76B	$311.05M	$3.49B	$1.07B
7 Day Performance	0.78%	-1.07%	-0.64%	-0.34%
1 Month Performance	9.09%	-1.62%	-3.78%	-0.53%
1 Year Performance	22.79%	26.23%	61.99%	19.19%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.8332 of 5 stars	$857.61 +0.2%	$962.67 +12.3%	+22.8%	$100.41B	$403.43B	22.29	43,000	Trending News Upcoming Earnings
DXCM DexCom	3.896 of 5 stars	$73.37 +2.6%	$85.36 +16.3%	+5.3%	$27.61B	$4.66B	30.70	11,000	Trending News Earnings Report Analyst Forecast Gap Down
HQY HealthEquity	4.0882 of 5 stars	$99.05 +4.7%	$110.93 +12.0%	+10.5%	$7.91B	$1.31B	26.36	2,814	Positive News
HSIC Henry Schein	3.3622 of 5 stars	$84.61 -1.0%	$88.62 +4.7%	+26.1%	$9.74B	$13.18B	25.56	25,000	Positive News Upcoming Earnings Analyst Upgrade
MMSI Merit Medical Systems	4.1863 of 5 stars	$76.10 +2.4%	$92.80 +21.9%	+0.3%	$4.43B	$1.52B	21.23	7,500	Trending News Earnings Report Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Summary

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Do analysts recommend MCK or DXCM?

Which has better valuation and earnings, MCK or DXCM?

Which has more volatility & risk, MCK or DXCM?

Is MCK or DXCM more profitable?

Does the media prefer MCK or DXCM?

Do institutionals & insiders hold more shares of MCK or DXCM?

Summary

How does McKesson compare to HealthEquity?

Do insiders & institutionals hold more shares of MCK or HQY?

Which has stronger earnings & valuation, MCK or HQY?

Do analysts rate MCK or HQY?

Does the media prefer MCK or HQY?

Which has more volatility and risk, MCK or HQY?

Is MCK or HQY more profitable?

Summary

How does McKesson compare to Henry Schein?

Does the media prefer HSIC or MCK?

Which has more volatility & risk, HSIC or MCK?

Which has better earnings & valuation, HSIC or MCK?

Do institutionals & insiders believe in HSIC or MCK?

Is HSIC or MCK more profitable?

Do analysts recommend HSIC or MCK?

Summary

How does McKesson compare to Merit Medical Systems?

Do analysts prefer MCK or MMSI?

Do insiders & institutionals hold more shares of MCK or MMSI?

Is MCK or MMSI more profitable?

Which has more volatility & risk, MCK or MMSI?

Which has stronger earnings and valuation, MCK or MMSI?

Does the media favor MCK or MMSI?

Summary

How does McKesson compare to AMN Healthcare Services?

Which has more volatility and risk, AMN or MCK?

Is AMN or MCK more profitable?

Do insiders and institutionals believe in AMN or MCK?

Do analysts prefer AMN or MCK?

Which has preferable earnings & valuation, AMN or MCK?

Does the media favor AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools